Arovella Therapeutics (E4NA.STU) Q1 2026 Earnings

19FebConfirmed
Q1 2026
-0
-0
-0
-0

Details

Expected EPS
-0.0022667817
Actual EPS
-0.00090671268
Surprise EPS
0
Surprise Percent
+60%

Description

Arovella Therapeutics (E4NA.STU) has reported earnings of -0.00090671268 per share for Q1 2026.

0 Comments

Share your thoughts